ATAI
Atai Beckley NV
NASDAQ · Healthcare · Medical - Pharmaceuticals · NL
$7.35
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 611.13x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 15.46x
- Price / sales
- 609.40x
- Price / cash flow
- -21.33x
Enterprise value
- Enterprise value
- $2.5B
- EV / sales
- 559.89x
- EV / EBITDA
- -3.69x
- EV / EBIT
- -17.10x
- Market cap
- $2.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026